Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▼ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Prothena Corp. plc | 13 | 0 | 2 | 0 | €19.10 | €78.70 | 312.045% |
| Resmed Inc. | 21 | 0 | 2 | 0 | €221.70 | €216.62 | -2.289% |
| UnitedHealth Group Inc. | 43 | 1 | 2 | 0 | €533.80 | €547.91 | 2.644% |
| Innoviva Inc. | 6 | 0 | 0 | 0 | €17.00 | €30.00 | 76.471% |
| QIAGEN NV | 12 | 0 | 1 | 0 | €40.47 | €47.52 | 17.415% |
| Centene Corp. | 26 | 0 | 4 | 0 | €69.74 | €82.38 | 18.120% |
| GSK plc ADR | 6 | 0 | 0 | 0 | €39.80 | €49.33 | 23.937% |
| Humana Inc. | 23 | 0 | 1 | 0 | €320.70 | €381.44 | 18.939% |
| LivaNova plc | 12 | 0 | 1 | 0 | €42.00 | €66.49 | 58.314% |
| Baxter International | 4 | 0 | 0 | 0 | €34.32 | €46.00 | 34.018% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €101.80 | €109.00 | 7.073% |
| Gilead Sciences Inc | 12 | 1 | 1 | 0 | €71.46 | €84.81 | 18.685% |
| Pfizer Inc. | 32 | 4 | 7 | 0 | €26.24 | €41.49 | 58.156% |
| Medtronic plc | 7 | 1 | 3 | 0 | €80.12 | €92.55 | 15.515% |
| Stryker Corp. | 31 | 0 | 7 | 0 | €326.10 | €340.93 | 4.547% |
| Lantheus Holdings Inc | 2 | 0 | 0 | 0 | €94.64 | - | - |
| Exact Sciences | 17 | 0 | 2 | 0 | €55.82 | €75.89 | 35.957% |
| Geron Corp. | 15 | 0 | 1 | 0 | €4.06 | €5.52 | 35.978% |
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €14.05 | - | - |
| Paul Hartmann AG | 4 | 0 | 1 | 0 | €197.50 | - | - |
| Evotec SE | 9 | 1 | 6 | 0 | €6.69 | €10.00 | 49.589% |
| Bio-Rad Labs Inc. A | 6 | 0 | 2 | 0 | €305.30 | €366.66 | 20.099% |
| Bio-Techne Corp. | 9 | 0 | 1 | 0 | €67.50 | €75.80 | 12.301% |
| Healthequity Inc. | 2 | 0 | 0 | 0 | €69.50 | €82.25 | 18.345% |
| Amgen Inc. | 28 | 0 | 3 | 0 | €301.95 | €304.82 | 0.950% |